AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes

Overview of attention for article published in Trials, August 2022

Altmetric Badge

Mentioned by

twitter: 13 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 17 X posts from 13 X users, with an upper bound of 62,690 followers.

AZTEC-azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes #NeoPapers #neoTwitter https://t.co/eugOfC2sBM

29 Aug 2022

Reply Repost Favourite

RT @neo_papers: AZTEC-azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical…

29 Aug 2022

Reply Repost Favourite

RT @neo_papers: AZTEC-azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical…

28 Aug 2022

Reply Repost Favourite

RT @neo_papers: AZTEC-azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical…

28 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.